Streptomycin has the structure shown in Fig.  1 . The streptidine moiety is synthesized by a series of reactions from myo-inositol (5, 6 ). An O-phosphorylstreptidine was found to be an intermediate in the biosynthetic pathway, but it was not known at what stage in the biosynthesis of streptomycin the phosphate group was removed, i.e., before or after addition of the L-streptose and N-methyl-L-glucosamine moieties (4, 7, 8) . In addition to the de novo biosynthetic pathway, synthesis of O-phosphorylstreptidine was also found to occur in intact mycelia of a number of strains of Streptomyces by phosphorylation of exogenous streptidine. Subsequently, it was shown that cell-free extracts from postexponential phase mycelia of streptomycinproducing strains catalyze phosphorylation of streptidine with adenosine-5'-triphosphate (ATP; 4). The observation that phosphorylation of streptidine was strongly inhibited by streptomycin and dihydrostreptomycin suggested that perhaps the latter compounds were also phosphorylated by the same enzyme (4) . In this paper, evidence is presented that enzyme preparations containing streptidine kinase activity also catalyze phosphorylation of streptomycin with ATP, and, furthermore, that the O-phosphoryl group appears to be located in the streptidine moiety.
MATERIALS AND METHODS Labeled compounds. (B, y-32P)ATP, 77 c/mole, came from Schwarz BioResearch Inc., Orangeburg, N.Y.; L-(guanidino-14C) arginine, 25 c/mole, came from Calbiochem, Los Angeles, Calif. Labeled aminocycitol derivatives were prepared as described elsewhere (5).
Enzyme preparations. Lysozyme extracts of 3-day mycelia of Streptomyces bikiniensis ATCC 11062 were prepared as described previously (5) . Nucleic acids were precipitated with MnCl2, and a 0 to 70% (NH4)2SO4 fraction was obtained; 1 ml of this fraction, containing 25 mg of protein, was applied to a Sephadex G-100 column (2.5 by 55 cm, void volume 85 ml), previously equilibrated with 0.01 M tris(hydroxymethyl)aminomethane (Tris; pH 7.4) and mercaptoethanol. Fractions of 2.5 ml were collected at 3 C; protein first emerged in tube 32. To aid in preserving enzyme activities during repeated freezing and thawing, 3 mg of bovine serum albumin was added to each tube.
Enzyme assays. Streptidine kinase activity was assayed radiochemically with (N'-amidino-14C)streptidine as acceptor (4), as was done for the Sephadex fractions, or as described below for streptomycin kinase activity shown fn Table 1 . Streptomycin (and dihydrostreptomycin) kinase activity was assayed typically as follows: streptomycin sulfate (0.4 mg/ml), 10 juliters; 0.5 ,uM Tris (pH 8.8) containing MgC12. 6H20 (1 mg/ml), 5 ,Aliters; Sephadex tube no. 48, 20 ,uliters; sodium (3,-y-2P)ATP solution, 2 juliters. The mixture was incubated for 2 hr at 37 C (30 min for Fig.   2 ). Compounds in a 10-juliter sample were then separated by ascending paper chromatography (25 cm) with 80% phenol and 20% water in an NH3 atmosphere (provided by adding 1 ml of concentrated NH40H on the inside of a jar); 1-cm horizontal strips were cut and counted in bottles by means of a liquid scintillation counter. For many studies (Tables  1 and 2 ; Fig. 4 ), the incubation volumes were scaled up 10-fold, and the mixtures subsequently were applied to small (Pasteur pipette) columns containing Dowex-I (Cl-) and eluted with 5 ml of water. ATP, adenosine diphosphate (ADP), adenosine monophosphate, and Pi were retained on the column; phosphorylated derivatives of streptomycin, dihy-401 MILLER AND WALKER drostreptomycin, and streptidine were not adsorbed. Eluates were evaporated to dryness and taken up in (i) 200 JAliters of water for counting (Table 1) Coincidence of streptidine kinase and streptomycin kinase activities. As reported previously (4), mycelial extracts contain factors which inhibit streptidine kinase activity. Consequently, a preliminary purification was carried out before testing streptomycin as an alternate substrate; an example is shown in Fig. 2 . Streptidine kinase activity can be separated more-or-less completely on a Sephadex G-100 column from a number of enzymes involved in streptidine biosynthesis, including the kinase which acts on the closely related compound, N-amidinostreptamine. Samples from the peak of streptidine kinase activity were also found to catalyze phosphorylation of streptomycin ( (Fig. 3A) . Results 
Transamidination does not occur with nonphosphorylated streptidine, streptomycin, or streptomycin-P. Substantial amounts of streptidine-P, as assayed by reaction 5, are formed as a result of reactions 6 plus 7 (Table 2) . It would appear, therefore, that the phosphate group is esterified on the streptidine moiety of streptomycin.
streptomycin + Mg-ATP -D (6) streptomycin-P + Mg-ADP streptomycin-P 1 N HCI 50 C
streptidine-P + streptobiosamine DISCUSSION The findings reported here are consistent with an identity of streptomycin kinase and the previously described enzyme, streptidine kinase (4) . In fact, the observation that at low concentrations streptomycin is a somewhat better phosphate acceptor than streptidine suggests that the enzyme might be more accurately designated as streptomycin kinase. The precise location of the phosphate group on the streptidine moiety is not known, but it can be narrowed down to one of two positions, 5 or 6 ( Fig. 1) , since one of the streptidine-OH groups is in glycosidic linkage with the streptose moiety, and the -OH group located between the two guanidino groups appears not to be involved, inasmuch as 2-deoxystreptidine can be phosphorylated by the enzyme (4).
The physiological role of streptomycin-P is not clear. Nomi and co-workers (2) have detected a compound (L-component) in culture broths during streptomycin production which is converted to streptomycin on incubation with a factor (H-component) with many of the characteristics of a phosphatase, and they suggest that the L-component is a biosynthetic precursor of streptomycin. Our enzymatically synthesized streptomycin-P might well be identical with Nomi's L-component. However, the occurrence in streptomycin-producing strains of an active streptomycin kinase raises the question of whether streptomycin-P is an obligatory precursor of streptomycin or a product of enzymatic phosphorylation of preformed streptomycin. Some of the alternative possibilities are depicted in Fig. 5 .
In biosynthetic pathway A, the phosphate group of streptidine-P is retained during addition of the streptose and N-methyl-L-glucosamine moieties, and streptomycin-P is the immediate precursor of streptomycin. Possible advantages of this pathway include easier retention of phosphorylated intermediates within the mycelium during biosynthesis and preservation of this potent inhibitor of protein synthesis (1) in an inactive phosphorylated form prior to secretion. A high concentration of inorganic phosphate in the culture medium might be expected to inhibit any dephosphorylation step involved in the biosynthesis of streptomycin.
In biosynthetic pathway B, intermediates following streptidine are not phosphorylated, and enzymatic phosphorylation serves as a detoxification mechanism or is in some manner related to a physiological function of streptidine-P or streptomycin-P in the producing organism. For Hopefully, further studies will help elucidate the function of streptomycin in these Streptomyces, as well as provide information of more general application to the problem of antibiotic synthesis and release into the medium.
